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Abstract: Toxoplasma gondii (T. gondii), the causative agent of toxoplasmosis, is a frequent cause of 
brain infection. Despite its known ability to invade the brain, there is still a dire need to better 
understand the mechanisms by which this parasite interacts with and crosses the blood–brain 
barrier (BBB). The present study revealed structural and functional changes associated with 
infection and replication of T. gondii within human brain microvascular endothelial cells (BMECs) 
in vitro. T. gondii proliferated within the BMECs and disrupted the integrity of the cerebrovascular 
barrier through diminishing the cellular viability, disruption of the intercellular junctions and 
increasing permeability of the BMEC monolayer, as well as altering lipid homeostasis. Proton 
nuclear magnetic resonance (1H NMR)-based metabolomics combined with multivariate data 
analysis revealed profiles that can be attributed to infection and variations in the amounts of certain 
metabolites (e.g., amino acids, fatty acids) in the extracts of infected compared to control cells. 
Notably, treatment with the Ca2+ channel blocker verapamil rescued BMEC barrier integrity and 
restricted intracellular replication of the tachyzoites regardless of the time of treatment application 
(i.e., prior to infection, early- and late-infection). This study provides new insights into the structural 
and functional changes that accompany T. gondii infection of the BMECs, and sheds light upon the 
ability of verapamil to inhibit the parasite proliferation and to ameliorate the adverse effects caused 
by T. gondii infection. 
Keywords: Toxoplasma gondii; blood–brain barrier; host response; host-pathogen interaction; 
metabolomics; verapamil 
 
1. Introduction 
Toxoplasma gondii is an obligate intracellular apicomplexan protozoan, known to infect at least 
one-third of the global human population [1,2]. T. gondii is also known to invade and proliferate 
within all eukaryotic cells and infect an extensive number of warm-blooded mammals. During the 
hematogenous dissemination of T. gondii, tachyzoites travel through the blood stream to invade 
tissues that are anatomically distant from the original site of infection. However, the brain is the most 
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common site where the latent stage of T. gondii is normally found [3,4]. Once inside the brain 
parenchyma, T. gondii preferentially infects neuronal cells and develops persistent tissue cysts in the 
brain [5]. Experimental evidence indicates that T. gondii crosses the blood–brain barrier (BBB) using 
a ‘Trojan horse’ mechanism, breaching the BBB paracellularly by targeting tight junction proteins or 
crossing the BBB by direct infection of endothelial cells [6–9]. 
Foci of T. gondii were observed surrounding microvessels in mice during reactivation of latent 
infection [10] and acute infection [11], indicating that T. gondii likely enters the brain through the 
vasculature, by breaching the formidable BBB [8]. To do this, they must adhere to, and cross, the 
endothelial cells lining blood vessel walls. In a study in mice, vascular endothelial cells were shown 
to serve as a replicative niche for the parasite which, after replication and bursting of endothelial 
cells, infected adjacent brain cells [11]. T. gondii infection was found to deregulate radial glia (RG) cell 
proliferation, differentiation potential, and decrease TGF-β1 levels. T. gondii infection of RG cells 
resulted in impairment of endothelial cell barrier functions through disorganization of cell junction-
associated ZO-1 and reduced trans-endothelial electrical resistance (TEER) [12]. Infection of primary 
human umbilical vein endothelial cells by T. gondii caused alteration of the morphology, barrier 
permeability, and transcriptional profile of the infected cells. T. gondii also disrupted the vascular 
endothelial cadherin and β-catenin localization to the cell margin, reduced vascular endothelial 
cadherin protein expression, and reduced filamentous actin stress fiber abundance under static and 
microfluidic shear stress conditions [13]. 
In a case-control study of patients with acute toxoplasmosis, serological evidence of T. gondii 
infection was associated with significant oxidative stress and pro-inflammatory changes which may 
contribute to development of endothelial dysfunction [14]. T. gondii infection of mice increased 
vascular inflammation, leukocyte-endothelial cell interaction, vasodilation, and BBB permeability 
[15]. Using a transgenic mouse model, Portillo et al. [16] showed that during interaction of infected 
leukocytes with endothelial cells, upregulation of CD40 and induction of autophagy protein-
dependent anti-parasitic activity in endothelial cells restricts T. gondii invasion of neural tissue. 
Despite these commendable efforts, the mechanisms by which T. gondii subverts the function of the 
BBB cells and crosses the BBB to cause neuropathy remain largely unresolved. 
Elucidating the initial interaction between T. gondii and brain vascular endothelial cells is 
important because this sets the stage for ensuing infection and may determine success, defined by 
establishment, survival, breach of the BBB, and dissemination to the central nervous system. While 
the outcomes of T. gondii interaction with the BBB reflect the properties of the parasite agent, it is also 
important to understand the response of the host BBB cells to infection. Although important in neuro-
pathogenesis, the interaction of T. gondii with brain microvascular endothelial cells (BMECs) has 
received less attention than other cell types. Therefore, in the present study, we investigated the 
phenotypic and functional changes that occur in the primary human BMECs during T. gondii 
infection. Our data provide new insights into the molecular mechanisms underpinning T. gondii-
induced BMEC barrier dysfunction. We also show that the Ca2+ channel blocker verapamil 
significantly reduced the proliferation of T. gondii tachyzoites and ameliorated the adverse impact of 
infection on barrier function. 
2. Materials and Methods 
2.1. Maintenance of Cell Cultures 
BMECs were grown at 37 °C in a humidified 5% CO2 atmosphere, as described previously 
[17,18]. Cells were cultured in Roswell Park Memorial Institute (RPMI) medium (Gibco, Paisley, UK) 
supplemented with 20% heat-inactivated fetal bovine serum (FBS); 2 mM L-glutamine; 1% sodium 
pyruvate; 1% non-essential amino acids; 1% vitamin, and 1% antibiotic-antimycotic solution (10,000 
units/mL penicillin, 10,000 µg/mL streptomycin, and 25 µg/mL Amphotericin B). Cells were sub-
cultured once a week. On reaching confluence, the cells were treated with trypsin- 
ethylenediaminetetraacetic acid (EDTA) and sub-cultivated at a ratio of 1:3 in new T-75 cm2 NUNC™ 
culture flasks with fresh RPMI medium. Cell viability was assessed with a hemocytometer following 
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staining with 0.15% trypan blue solution. Media, FBS, media supplements, and antibiotics were 
purchased from Gibco (Life Technologies, MA, USA). Flasks were incubated at 37 °C in a 5% CO2 
atmosphere, and cultured media were renewed twice a week. Madin-Darby Canine Kidney cells 
(MDCK) were obtained from the European Collection of Authenticated Cell Cultures (ECACC, 
Salisbury, UK). MDCK cell cultures were maintained in complete Dulbecco’s modified Eagle’s 
medium (DMEM; Gibco, Paisley, UK), supplemented with 10% heat-inactivated FBS, 2 mM 
glutamine, and 1% antibiotic-antimycotic solution at 37 °C in a humidified 5% CO2 atmosphere. 
2.2. Propagation and Purification of Toxoplasma gondii Tachyzoites 
Tachyzoites of T. gondii RH strain (genotype I) were maintained by passage in MDCK cell 
cultures. MDCK culture flasks infected with T. gondii were observed daily using a Leica DM 1L 
inverted microscope (Leica Microsystems, Buffalo Grove, IL, USA). When > 80% of the cell monolayer 
were destroyed, a cell scraper was used to detach the remaining cells in the flask. Detached cells and 
media were collected into a 50 mL tube and centrifuged at 3000× g for 5 min. The supernatant was 
discarded and the pellet was re-suspended in fresh culture medium. Tachyzoites were purified from 
their feeder-cell cultures by passing through PD-10 desalting columns packed with Sephadex G-25 
[19]. The purified parasites were then centrifuged at 800× g, re-suspended in fresh culture medium 
and counted with a Neubauer hemocytometer counting chamber (Marienfeld Superior; Paul 
Marienfeld GmbH and Co, Lauda-Königshofen, Germany) and a Leica DM 1L inverted microscope. 
2.3. Infection of Brain Microvascular Endothelial Cells (BMECs) 
To optimize the host cell-to-parasite ratio, BMECs were seeded in 24-well hanging cell culture 
inserts (3.0 µm PET, Merck Millipore, Darmstadt, Germany) at 104 cells/insert. After 5 days of 
incubation, BMEC monolayers grown in two inserts were trypsinized, and detached cells were 
counted in order to determine the multiplicity of infection (MOI). The final volume of purified 
tachyzoite suspension was adjusted with fresh RPMI medium to achieve a MOI of 5 (5 tachyzoites to 
1 host cell) in each insert, this was used in all subsequent experiments, unless otherwise stated. 
Uninfected control cells were sham-infected with an equal volume of RPMI medium devoid of 
tachyzoites. After 3 h of incubation, the media from all wells were discarded and replaced with fresh 
RPMI medium. All experiments were performed in triplicate, and the data represent the mean ± 
standard error of the mean (SEM) from at least three independent experiments. 
2.4. Phenotypic Characterization of Infection 
2.4.1. AlamarBlue® Viability Assay 
The effect of T. gondii infection on cell viability was assessed with the alamarBlue® assay 
according to the manufacturer’s instructions (Invitrogen, Carlsbad, CA, USA). This assay is based on 
the reduction of blue non-fluorescent resazurin (7-Hydroxy-3H-phenoxazin-3-one 10-oxide) to pink 
fluorescent resorufin, and finally to dihydroresorufin, by the action of cytoplasmic and mitochondrial 
enzymes in viable cells. AlamarBlue® reagent is an oxidation-reduction indicator that fluoresces red 
when it accepts electrons generated by cellular metabolism. The quantity of resorufin produced is 
directly proportional to cellular metabolic activity (i.e., indirectly proportional to the number of living 
cells). BMECs were seeded in 96-well culture plates, at 5 × 103 cells/well, and grown in 100 µL of RPMI 
medium per well at 37 °C in a humidified 5% CO2 atmosphere. After 24 h of incubation, the 
tachyzoites were added to the cell monolayers. At 6, 24, or 48 h post-infection (hpi) 10 µL of the 
alamar dye was introduced into each well. After 4 h of incubation at 37 °C, color changes were 
determined with a double-wavelength (570 and 630 nm) measurement on a microplate reader 
(Labtech International Ltd., Ringmer, UK). Cell survival was expressed as a percentage of the 
absorbance values measured from wells containing uninfected control cells. 
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2.4.2. Fluorescence Staining 
The growth of T. gondii tachyzoites within BMECs was monitored using Acridine Orange (AO; 
3-N,3-N,6-N,6-N-tetramethylacridine-3,6-diamine) staining. The AO staining assay is based on the 
permeation of AO into eukaryotic cell and organelle membranes, and emitting green fluorescence 
when bound to double-stranded DNA, or red fluorescence when bound to single-stranded DNA or 
RNA. The developing intracellular tachyzoites were identified by their characteristic shape and size 
dimensions. BMECs were seeded onto cover slips in six-well cell culture plates (Corning, Corning, 
New York, USA) at a concentration of 105/mL, in 2 mL of RPMI medium, and allowed to adhere for 
24 h. Tachyzoites were then added as detailed above. At 6, 24, or 48 hpi the coverslips were removed 
from the wells, washed twice in 1x phosphate buffered saline (PBS), fixed in 4% paraformaldehyde 
(PFA) for 30 min, and stained with 10% AO for 10 min at ambient temperature and protected from 
light. Following staining, coverslips were washed twice in PBS and mounted onto a microscopic glass 
slide. Fluorescence was observed using a Leica Microsystems DM-5000B epifluorescence microscope 
equipped with a charge-coupled-device camera (Leica Microsystems, Buffalo Grove, IL, USA). All 
images were generated using identical exposure times and camera settings. Quantification of the 
surface area of the AO-stained tachyzoites was performed using ImageJ® software version 15.0 
(https://imagej.nih.gov/ij/). 
2.4.3. Scanning Electron Microscopy (SEM) 
BMECs were grown to confluence on 12-mm glass coverslips (Corning, NY, USA). Tachyzoites 
were added in RPMI medium and incubated at 37 °C for 6, 24, or 48 hpi. Medium was then removed, 
and monolayers were rinsed in 1 M cacodylate buffer, fixed with 5% (w/v) glutaraldehyde in 0.1 M 
Na-cacodylate buffer for 30 min at ambient temperature, and finally washed with 0.1 M Na-
cacodylate buffer. The cells were post-fixed with 1% aqueous osmium tetroxide in 0.1 M Na-
cacodylate buffer, pH 7.4, at 25 °C for 90 min, and washed with 0.1 M Na-cacodylate buffer. Following 
fixation, cells were dehydrated with a 15% graded ethanol series, and dried in a critical point dryer. 
The samples were then coated with a 20 nm layer of gold/palladium (60:40) in a Balzersunion coater 
for 15–30 min to increase the specimen’s conductivity. Images were obtained with a Jeol 6060 LV SEM 
(JEOL, Tokyo, Japan) and using the in-built SEM Control User Interface software (version 6.57). 
2.4.4. Transmission Electron Microscopy (TEM) 
Tachyzoites were added to confluent monolayers of BMECs grown on Thermo Scientific™ 
Nunc™ Thermanox™ Coverslips (13 mm in diameter) in 24-well plastic plates in RPMI medium and 
incubated at 37 °C in 5% CO2. At 6, 24, or 48 hpi, coverslips with monolayers were washed three times 
in 0.1 M cacodylate buffer for 10 min at ambient temperature, and fixed in electron microscopy (EM) 
fixative buffer (3% glutaraldehyde prepared in 0.1 M cacodylate buffer) for 60 min at 4 °C. After 
fixation, each specimen was washed three times in the same buffer for 10 min, and post-fixed for 30 
min with 1% aqueous osmium tetroxide prepared in 0.1 M cacodylate buffer. Thereafter, each 
specimen was washed in water five times for 1 min. The specimens were subsequently dehydrated 
in a graded series of ethanol dilutions using the following protocol: Twice in 50% ethanol for 5 min; 
twice in 70% ethanol for 5 min; twice in 90% ethanol for 5 min; and thrice in 100% ethanol for 10 min. 
The specimen was then infiltrated and polymerized with resin, sectioned, and stained with ethanolic 
uranyl acetate followed by lead acetate. Cells were imaged with a FEI Tecnai G2 12 Biotwin TEM 
system (FEI, Eindhoven, Netherlands) run at an acceleration voltage of 120 Kilo volt. 
2.5. Analysis of Neutral Lipids 
LipidTox™ is a green neutral lipid stain that detects intracellular lipid droplets (LDs) within 
mammalian cells. This assay is based on the permeation of LipidTox into cell and tachyzoite 
membranes and emitting green fluorescence when bound to LDs. BMECs were seeded on six-well 
cell culture plates on cover slips (Corning, NY, USA) at a density of 105/mL in RPMI medium. Once 
a confluent cell monolayer is formed (~24 h) tachyzoites were added as described above. The cover 
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slips were removed from the wells at 6, 24, or 48 hpi, washed twice in PBS, fixed in cold 
acetone:methanol (1:1 v/v) for 10 min and stained with LipidTox in a 1:400 dilution for 30 min as per 
the manufacturer’s instructions (Invitrogen, Carlsbad, CA, USA). The nucleus was counter-stained 
with ProLong Gold antifade reagent with 4′,6-diamino-2-phenylindole dihydrochloride (DAPI; 
Molecular Probes, Eugene, OR, USA). Samples were observed under a Zeiss LSM880 confocal laser 
scanning microscope (Carl Zeiss, Oberkochen, Germany) equipped with a monochrome C-4742-95 
camera (Hammamatsu Photonics KK, Japan). Quantification of the surface area of stained cells (n = 
20 cells/group) was performed using image-Pro Plus® software version 6.0 (Media Cybernetics Inc, 
Rockville, MD, USA). 
2.6. Endothelial Cell Integrity and Permeability Studies 
The influence of infection on the function of the BMEC monolayer was investigated using a 
TEER assay, AO staining of the BMEC monolayer on the insert mesh, and a fluorescein 
isothiocyanate-labeled dextran (FITC-dextran) transmigration assay. 
2.6.1. TEER Measurements 
We measured the electrical resistance across the BMEC monolayer using the TEER assay in order 
to assess the integrity and permeability of the BMEC monolayer following T. gondii infection. Higher 
electrical resistance indicates a higher integrity and lower permeability of the cell monolayer, 
whereas low electrical resistance indicates a compromised, more permeable cell monolayer. Cells 
were grown on cell culture inserts (0.4 µm pore size) (24-well Millicell® Cell Culture Inserts, Millipore, 
Watford, UK) fitted in 24-well cell culture plates at 5 × 103 cells/well in RPMI medium, at 37 °C in a 
humidified 5% CO2 atmosphere. Growth medium was replaced with fresh medium the following 
day. On day five after culturing, the cell monolayers became confluent and tachyzoites were added. 
TEER was measured using an EVOM Voltohmmeter and STX2 electrodes (World Precision 
Instruments, Inc., Sarasota, FL, USA). The electrodes were equilibrated by inserting into a well with 
the cell culture insert without cells, but with RPMI medium for 5 min at ambient temperature. The 
value of the blank wells always increases the total resistance measured across a cell culture 
membrane, and this value was subtracted from the resistance reading of wells with cells to obtain 
‘actual resistance.’ The electrodes were used to measure the control wells first, followed by the 
infected wells. Also, the electrodes were cleaned with 70% ethanol and rinsed with sterile PBS 
between measurements to avoid cross-contamination of the uninfected culture inserts. One electrode 
was inserted in the medium covering the BMEC monolayer, while the other electrode was inserted 
in the medium on the outside of the transwell. TEER readings were recorded at 0, 3, 6, 24, 48, 72, 96, 
120, 144, and 168 hpi. To calculate TEER (Ω·cm2), electrical resistance reading of inserts without cells 
was subtracted from the readings obtained from inserts with cells, and this value was multiplied by 
the surface area of the insert (0.33 cm2). 
2.6.2. Fluorescein Isothiocyanate (FITC)-Dextran Leakage Through the BMEC Barrier 
The integrity of the BMEC monolayer grown on Transwell plates was assessed using FITC-
dextran (4000 molecular weight, Sigma-Aldrich). Purified tachyzoites were added to confluent cells 
plated on Transwell plates. The plate was incubated for 1 h at 37 °C and then, 0.3 mL of FITC-dextran 
in culture medium (1 mg/mL) was added into the upper chamber in the Transwell inserts (the apical 
side), while 1.3 mL complete RPMI was added into the lower chamber. Monolayer permeability was 
assayed by measuring FITC-dextran leaked into the bottom chamber of the Transwell (the basolateral 
side) at 3, 6, 24, 48, and 72 hpi. At each time point after infection the medium in the lower chamber 
was pipetted several times to evenly mix the leaked FITC-dextran with culture medium before 200 
µL of the media was transferred into two wells of 96-well plate, 100 µL/well. Fresh medium (200 µL) 
was added to each lower compartment to replace the collected medium. The leaked FITC-dextran 
concentration from the upper chamber to the lower chamber of each well was measured with a 
Varioskan Flash plate reader (Thermo Fisher Scientific, MA, USA) in ‘Fluorometric Measurement’ 
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mode, with excitation and emission wavelengths of 485 nm and 518 nm, respectively. The leakage of 
FITC-dextran across the inserts was calculated as a percentage of the total amount added to the upper 
chamber. The fold change in FITC-dextran fluorescence intensity in infected wells, over that of mock-
treated controls (inserts with BMECs and FITC-dextran), was used as a measure of the paracellular 
permeability of the BMEC monolayers. We also examined the resistance of the BMEC monolayer 
following T. gondii infection, in the presence or absence of FITC-dextran, using the TEER assay. 
Measurements were recorded up to 168 hpi. 
2.6.3. Evaluation of Parasite-Crossing using Carboxyfluorescein Succinimidyl Ester (CFSE) Staining 
The CFSE stain was mixed with T. gondii at a concentration of 2 µL CFSE: 200 µL suspension of 
T. gondii tachyzoites. The mixture was incubated at 37 °C in 5% CO2 for 3 h, followed by centrifugation 
for 3 min at 3500× g. The supernatant was discarded and the pellet was re-suspended in 1 mL of RPMI 
medium. The number of stained tachyzoites was counted and added to wells in the Transwell plates. 
RPMI medium was used to top-up the wells. Five hundred microliters was removed from under the 
hanging insert at 3, 6, 24, 48, 72, 96, 120, 144, 168, and 192 hpi and the number of tachyzoites was 
determined with a Neubauer hemocytometer counting chamber (Marienfeld Superior; Paul 
Marienfeld GmbH and Co, Lauda-Königshofen, Germany) and a Leica DM 1L inverted microscope 
(Leica Microsystems, Buffalo Grove, IL, USA). An equal volume of fresh RPMI medium was added 
to the bottom chamber, below the insert, to replenish the medium used for counting the parasites that 
crossed the BMEC monolayer grown on the insert membrane. We also tested whether the decreased 
integrity of the BMECs was due to the addition of T. gondii only or aggravated by FITC-dextran, by 
comparing the number of tachyzoites crossing the BMEC monolayer in the presence or absence of 
FITC-dextran. Measurements were recorded until 168 hpi using a hemocytometer. 
2.6.4. Effect of Infection on the Integrity of the BMEC Monolayer 
Once the TEER experiment was finished inserts were emptied completely, rinsed gently using 
distilled water, and fixed in 4% PFA for ~15 min. Inserts were washed again with distilled water 
before 100 µL of 2% AO was added to control and T. gondii-infected BMECs. Inserts were kept in the 
dark for 20 min, followed by washing with distilled water. The mesh at the bottom of the inserts was 
removed using a scalpel and was placed on a glass slide. The mesh was imaged using a Leica DM 1L 
inverted microscope (Leica Microsystems, Buffalo Grove, IL, USA). Also, we used carboxyfluorescein 
succinimidyl ester (CFSE; Celltrace™ Thermo Fisher, Altrincham, UK) staining to compare the effect 
of T. gondii on the intactness and integrity of the BMEC monolayer. CFSE stain was added to control 
and T. gondii-infected BMECs. The mesh was imaged using a Leica DM 1L inverted microscope and 
a Leica DM5000 B (Leica Microsystems, Buffalo Grove, IL, USA). 
2.7. 1H NMR-based Metabolomics 
2.7.1. Sample Preparation and Data Acquisition 
BMECs were seeded in T75 (75 cm2) NUNC™ tissue culture flasks (2 × 106 cells/flask) (Fisher 
Scientific, Leicestershire, UK) and grown in RPMI medium as described above. Once a confluent cell 
monolayer was formed (~24 h), the tachyzoites were added at a MOI of 2. At 6, 24, and 48 hpi, the 
infected and uninfected cells were harvested using a cell scraper, followed by washing three times 
with cold PBS. The BMECs (infected and uninfected) and tachyzoite pellets were extracted with 2 mL 
of cold methanol/water (80:20) [20]. Purified tachyzoites were processed separately to identify the 
metabolic structure of the tachyzoites without any contribution from the host cells. The cells and 
tachyzoites were subjected to snap-freezing in liquid nitrogen and defrosted on dry ice in three cycles. 
The cells including the tachyzoites were pelleted by centrifugation at 20,400× g for 5 min at −9 °C. The 
supernatant was transferred to a clean tube and lyophilized. Prior to NMR analysis, the dried extract 
was reconstituted in 550 µL of deuterated water [D2O, 99.9%; Sigma-Aldrich] containing 0.01% of 
sodium 3-(trimethylsilyl) propionate-2, 2, 3, 3-d4 [TSP, Sigma-Aldrich] as an internal standard. The 
total volume (550 µL) of the solution was then transferred into 5 mm NMR tubes for subsequent 
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analysis. The data represent at least three independent experiments with six replicates per experiment 
to identify alterations in the metabolism of infected BMECs compared to uninfected control cells. All 
1H NMR spectra from the BMECs (infected and uninfected) and the purified tachyzoite extracts were 
obtained at 600 MHz using a Bruker AVANCE III spectrometer (Bruker Biospin; Rheinstetten, 
Germany) equipped with 5 mm Broadband/1H probe (Bruker SMART probe). Data were acquired 
using water pre-saturation and 32K data points were acquired and averaged using 512 scans. 
2.7.2. Spectra Processing and Multivariate Analysis 
NMR spectra were processed with an exponential window function of 0.3 Hz line broadening 
prior to Fourier transform. Spectra were then individually phased, baseline-corrected, and calibrated 
to the TSP reference peak at δ 0.00 in Topspin (version 3.1, Bruker). The region containing residual 
water resonance (4.7 ppm) was excluded to avoid any interference with the data analysis. The spectra 
were normalized over the total remaining spectral area using MATLAB (R2008a, MathWorks, Inc., 
2008, Natick, Massachusetts, US) to improve data quality and remove biases. Multivariate statistical 
analysis, including principal component analysis (PCA), partial least squares discriminant analysis 
(PLS-DA), and orthogonal projections to latent structures (OPLS)-DA were performed on the 
normalized spectra using SIMCA-P+ 11.0 software (Umetrics, Umea, Sweden). First, we used an 
unsupervised PCA approach to detect intrinsic clusters and possible outliers within the data set. 
Next, supervised PLS-DA modeling was applied to improve class discrimination between the two 
groups (infected versus control). PLS-DA utilizes prior information of class membership and hence 
optimizes separation [21]. The validity of the model was evaluated using R2 and Q2 values, where R2 
represents the proportion of variance in the data explained by the model and suggests goodness of 
fit, and Q2 shows the predictability of the model. R2 and Q2 > 0.5 indicate that the model is fit and 
robust. Additionally, OPLS-DA was used to maximize the separation between the infected group and 
the control group. This method enhances the recovery of infection-related metabolites and removes 
variation unrelated to infection status using an orthogonal signal correction (OSC) filter. To identify 
the individual metabolites responsible for discriminating infected BMECs from controls, color map 
coefficient plots were applied. 
2.8. The Effect of Verapamil on BMEC Function 
We investigated the inhibitory effect of verapamil (Sigma-Aldrich; St Louis, MO, USA) on the 
proliferation of T. gondii tachyzoites and on offsetting the increased permeability of the BMEC 
monolayer caused by T. gondii infection. We tested the hypothesis that verapamil could enhance the 
BMEC monolayer integrity by limiting parasite growth. 
2.8.1. Inhibitory Effect of Verapamil on T. gondii Growth 
We investigated whether pre-treatment with verapamil inhibited the in vitro growth of 
tachyzoites, by incubating freshly purified tachyzoites with three concentrations of verapamil (1 µM, 
10 µM, or 100 µM) for 3 h at 37 °C and 5% CO2. The treated tachyzoite suspension was centrifuged at 
3000× g for 5 min. The supernatant was discarded and the parasite pellet re-suspended in 1 mL RPMI 
medium. The pre-treated tachyzoite suspension was added at a MOI of 5 to BMECs seeded in 24-well 
culture plates at ~2 × 104 cells/well in 1 mL RPMI medium, and the wells were topped-up with RPMI 
to 2 mL per well. We also tested the antiparasitic effect of early verapamil treatment. Each well with 
cell monolayer in 2 mL RPMI medium was infected with T. gondii at a MOI of 5, or mock-infected 
with medium only. The plate was incubated for 3 h at 37 °C in 5% CO2. Media were then removed 
from the wells and verapamil was added at the three concentrations in RPMI medium. In a third 
experiment, the antiparasitic effect of late verapamil treatment was also tested. Confluent cells grown 
in 2 mL RPMI medium in wells were infected with T. gondii at a MOI of 5, or mock-infected using 
medium without tachyzoites. The plate was incubated for 24 h at 27 °C and 5% CO2. Medium was 
then removed from the wells and verapamil was added at the three concentrations in RPMI medium. 
The plates were checked every 24 h to monitor the tachyzoites’ egress from the cells using a Leica 
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DM 1L inverted microscope (Leica Microsystems). Once the tachyzoites exited the control (untreated) 
infected cells (~3 days post infection), 1 mL of medium was removed from each well, and the number 
of extracellular parasites was counted using a Neubauer hemocytometer counting chamber and Leica 
DM 1L inverted microscope. 
2.8.2. Effect of Verapamil on BMEC Monolayer Integrity 
BMECs were seeded on microporous polycarbonate membrane filters (3 µm pore size; 24 mm 
diameter; Transwell 3414; Costar, Corning, NY, USA), and confluent monolayers were infected with 
tachyzoites at a MOI of 5 or mock-infected. Changes in the TEER values, and thus the integrity of the 
cell monolayer following T. gondii infection up to 120 hpi, with and without treatment with three 
concentrations of verapamil (1 µM, 10 µM or 100 µM), were measured using the TEER assay as 
detailed above. 
2.9. Statistical Analysis 
All statistical analyses were conducted using GraphPad Prism version 7.02 (GraphPad® Software 
Inc., San Diego, CA, USA). Statistical differences in host cell viability, integrity of EC monolayers, 
and surface area of the stained lipids between control (uninfected) and infected samples at different 
times after infection were analyzed using two-way analysis of variance (ANOVA). The Bonferroni 
test was used for post-hoc analysis as appropriate. Changes in the surface area of AO-stained 
tachyzoites over time were analyzed using one-way ANOVA and Tukey’s test was used for post-hoc 
analysis. Data are representative of at least three independent experiments and are expressed as 
means ± standard errors of the means (SEM) where p values < 0.05 were considered statistically 
significant. Significance for all statistical tests is described in the figure legends. 
3. Results 
3.1. Effects of T. gondii on the Viability and Structure of BMECs 
Analysis of the viability of BMECs with an alamarBlue® assay using two-way ANOVA revealed 
both a significant main effect of group (F (1, 34) = 15.08, p = 0.0005) and time (F (2, 68) = 257.3, p < 
0.0001), as well as a significant group × time interaction (F (2, 68) = 9.697, p = 0.0002) (Figure 1). Post-
hoc analysis revealed that infected cells showed significantly decreased viability, when compared to 
uninfected controls at 48 hpi (p < 0.0001). As shown in Figure S1, analysis of the AO-stained parasite-
specific surface area using one-way ANOVA revealed a significant main effect of time (F (2, 4) = 630.9, 
p < 0.0001) and post-hoc analysis indicated an increase in parasite growth inside infected cells at 48 
hpi when compared with 6 and 24 hpi (p < 0.001). This result was supported by microscopic 
examination of stained cells which showed more parasite divisions and larger collections of dividing 
tachyzoites that were evident at 48 hpi (Figure 2). 
 
Figure 1. T. gondii reduced the viability of BMECs. Absorbance was reduced in infected, compared to 
control, cells at 48, but not 6 or 24, hpi (****, p < 0.0001), indicating reduced viability of infected cells. 
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Figure 2. T. gondii development within BMECs. Representative images of BMECs infected by T. gondii 
tachyzoites and stained with AO at 6, 24, and 48 hpi. Numerous intracellular tachyzoites (indicated 
by arrows) were observed in infected BMECs, particularly at 48 hpi. Cellular DNA and RNA are 
shown in green and red, respectively. 
SEM analysis of BMECs infected by tachyzoites at the early stage of infection (6 hpi), showed 
crescent-shaped tachyzoites in close contact with host cells (Figure 3B), with their anterior ends 
embedded in the intercellular space (Figure 3C). Normal tight junctions (TJs) in control cells are 
shown in Figure 3A and tachyzoites disrupted them over time (Figure 3C–E). By 48 hpi, tachyzoites 
were observed exiting from host cells (Figure 3F). TEM analysis of uninfected cells showed normal 
TJs (Figure 4A–B); however, infected BMECs showed that tachyzoite proliferation disrupted the TJs 
in infected cells over time (Figure 4C–D). Host-cell organelles, including mitochondria (Figure 4E), 
endoplasmic reticulum (ER) (Figure 4F), and Golgi apparatus (Figure 4G), were observed in close 
proximity to the parasitophorous vacuole (PV); this became less evident by 48 hpi (Figure 4H). 
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Figure 3. Scanning electron micrographs of BMECs infected by T. gondii tachyzoites. (A) A confluent 
monolayer of uninfected control BMECs showing normal intercellular space (arrow). (B) At 6 hpi 
tachyzoites came in close contact with cells, with the anterior ends of the tachyzoites embedded in the 
intercellular space (C). A large gap is evident between infected cells at 24 and 48 hpi (D,E), compared 
to 6 hpi (B,C) and to uninfected control cells (A). By 48 hpi tachyzoites were observed exiting from 
the host cell (F) and a number of newly generated tachyzoites were visible (arrow). 
 
Figure 4. Transmission electron micrographs of BMECs infected by Toxoplasma gondii tachyzoites. 
(A,B) Control host cell (H) showing microvilli and normal intercellular tight junctions (TJ). Infected 
cells at 24 hpi (C) and 48 hpi (D) developed larger gaps as the infection advanced. At 24 hpi 
mitochondria (m) were found condensed around the parasitophorous vacuole membrane (PVM) that 
enclosed the tachyzoites (Tg) (E). The presence of the ER (F) and Golgi apparatus (Go) (G) around the 
PVM was also observed. By 48 hpi tachyzoites were getting ready to exit the PV (H). 
3.2. Perturbed Lipid Homeostasis in Infected Cells 
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Analysis of the LipidTox staining using two-way ANOVA revealed significant main effects of 
group (F (1, 12) = 14.33, p = 0.0026) and time (F (2, 24) = 12.7, p = 0.0002) but no group × time interaction 
(F (2, 24) = 2.717, p = 0.0864). Post-hoc testing revealed that staining was significantly increased in 
infected, compared to control, cells across all time points (p < 0.01) (Figure 5A). These results are 
consistent with the microscopic examination of the fluorescent images, which showed slight 
enhancement in cytoplasmic LD formation in BMECs due to T. gondii infection, which was only more 
prominent at 48 hpi (Figure 5B). 
 
Figure 5. T. gondii increased the lipid content of the infected BMECs. (A) Infected cells exhibited 
increased LipidTox™ green fluorescence intensity, compared to control cells (** p < 0.01). (B) 
Representative images of BMECs infected by T. gondii showing increased lipid staining denoted as 
green dots and blue host cell nuclei stained with 4′,6-diamidino-2-phenylindole (DAPI). 
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3.3. Disruption of BME Barrier Integrity by Infection 
To assess the integrity of the BMEC membrane, changes in the resistance of the cell monolayer 
grown on Transwell inserts following the addition of T. gondii were quantified over 168 h using a 
TEER assay (Figure 6A). The analysis revealed significant main effects of group (F (1, 4) = 206, p = 
0.0001) and time (F (9, 36) = 20.3, p < 0.0001), as well as a significant group x time interaction (F (9, 36) 
= 52.62, p < 0.0001). Post-hoc testing revealed that while the resistance of control and infected cells did 
not differ from 0–6 hpi (p > 0.05), infected cells did show significantly decreased resistance, compared 
to control cells, from 24–168 hpi (p < 0.0001). FITC-dextran was quantified in control and T. gondii-
infected cells using FITC-dextran leakage analysis (Figure 6B). The analysis revealed significant main 
effects of group (F (2, 6) = 16,774, p < 0.0001) and time (F (5, 30) = 15,150, p < 0.0001), as well as a 
significant group x time interaction (F (10, 30) = 10,349, p < 0.0001). Post-hoc testing revealed that 
while there was no difference in FITC-dextran between control and infected cells from 0–6 hpi (p > 
0.05), infected cells showed significantly increased FITC-dextran, compared to control cells, from 24–
72 hp (p < 0.0001). This indicates an increase in barrier permeability due to T. gondii infection.  
FITC-dextran was added to T. gondii-infected and control cells to determine if differences in 
TEER were due to T. gondii alone or if they also involved FITC-dextran. Adding FITC-dextran to 
uninfected cells allowed us to determine whether the FITC-dextran caused any further damage to the 
cell integrity or alter the TEER values (Figure 6C). The analysis revealed significant main effects of 
group (F (3, 6) = 126.3, p < 0.0001) and time (F (9, 54) = 12.45, p < 0.0001), as well as a significant group 
x time interaction (F (27, 54) = 17.35, p < 0.0001). Post-hoc testing revealed that there were no 
differences in resistance between control and infected cells in the presence or absence of FITC-dextran 
from 0–6 hpi (p > 0.05). In contrast, infected cells showed significantly decreased resistance, compared 
to control cells, from 24–168 h (p < 0.0001). There were no differences in resistance between control 
cells in the presence or absence of FITC-dextran except at 48 hpi, when cells with FITC-dextran 
showed significantly increased resistance compared to cells without FITC-dextran (p < 0.05). 
Importantly, resistance did not differ between infected cells in the presence or absence of FITC-
dextran at any time point examined (p > 0.05). This indicates a lack of effect of FITC-dextran on the T. 
gondii-induced increase in BMEC monolayer permeability.  
The number of T. gondii tachyzoites crossing the infected cell monolayer was quantified using a 
hemocytometer at 3, 6, 24, 48, 72, 96, 120, 144, 168, and 192 hpi. As shown in Figure 6D, the first 
tachyzoites to cross the cell monolayer were observed at 6 hpi, with ~2 × 105 crossing at 48 h; however, 
at 72 hpi in excess of 8.5 × 105 tachyzoites crossed the barrier. After 96 hpi, the number of tachyzoites 
crossing the monolayer declined over time. FITC-dextran was also added to T. gondii-infected cells to 
test whether the presence of FITC-dextran would affect the parasite crossing the barrier (Figure 6E). 
The analysis revealed a significant main effect of time (F (9, 36) = 29.93, p < 0.0001) but no main effect 
of group (F (1, 4) = 0.03489, p = 0.8609) or group x time interaction (F (9, 36) = 0.6228, p = 0.7697. The 
majority of tachyzoites crossing the barrier occurred between 48 and 96 hpi but FITC-dextran had no 
effect. 
To visualize the intactness of the BMEC monolayer on the membrane in the inserts, the inserts 
of infected and uninfected BMEC monolayers were stained with AO. T. gondii-infected BMECs 
showed minimal staining, indicating that few cells remained on the insert membranes. In contrast, 
control inserts containing BMECs only were evenly stained orange, indicating that the BMEC 
monolayer remained intact on the insert membranes (Figure 6F). Finally, inserts were stained with 
CFSE to localize the parasites in relation to the presence or absence of a cell monolayer. Cells can be 
observed in control samples containing BMECs only (Figure 6G); however, BMECs infected by T. 
gondii had a complete lack of cells, indicating cell loss due to the proliferation of tachyzoites. Control 
BMECs showed an intact cell monolayer, with arrows indicating notable cell outlines, whereas T. 
gondii-infected BMECs showed no cells present, reflecting the damage in the BMEC monolayer 
(Figure 6H). 
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Figure 6. T. gondii compromised the BMEC monolayer integrity. (A) Infected cells show decreased 
resistance compared to controls from 24 h onwards. (B) T. gondii significantly increased FITC-dextran 
flux in the cell monolayer compared to control BMECs + FITC-dextran. (C) Resistance was decreased 
in infected, compared to control, cells from 24–168 h, regardless of the presence or absence of FITC-
dextran. (D) There was a large number of tachyzoites crossing the cell monolayer after 48 h. There 
was still, however, a small number of tachyzoites crossing between 6 and 24 hpi and the numbers 
started declining after 96 hpi. (E) There was no difference between the number of parasites crossing 
the cell monolayer in infected cells in the presence or absence of FITC-dextran (p > 0.05), suggesting 
the decreased integrity of the cells was due to T. gondii only. (F) Inserts containing uninfected control 
cells displayed dark even orange staining (bottom row). Inserts with T. gondii-infected cells displayed 
minimal staining (top row). As AO stain binds to cells, the lack of orange staining indicates few/no 
cells are present. (G) CFSE staining showed that control cells maintained an intact cell monolayer, 
with arrows indicating notable cell outlines (top row). T. gondii-infected cells showed no cells, 
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indicating that the monolayer has been damaged. The dark cylinders are not cells; they are fibers from 
the insert indicated by red arrows. (H) CFSE staining showed an intact control cell monolayer in the 
top row indicated by green staining (arrow). The bottom row shows a lack of cells; however, 
tachyzoites were observed (arrow) that were identifiable by the shape and the relative size, indicating 
that the cell monolayer has been damaged. **** p < 0.0001, compared to the control. 
3.4. Determination of Metabolic Differences between Infected and Uninfected Cells 
1H NMR spectra of infected and uninfected BMECs at different infection times were subjected 
to multivariate statistical analysis. The dominant metabolites were detected and quantified based on 
their chemical shifts and signal multiplicity, including isoleucine, leucine, valine, lactate, alanine, 
acetate, glutamate, glutamine, aspartate, creatine, choline, phosphocholine, glycerophosphocholine, 
scyllo-inositol, taurine, and myo-inositol (Table S1). To identify the metabolites associated with 
infection, we employed PCA, PLS-DA, and OPLS-DA. Initially, PCA was applied to the spectra of 
infected and uninfected BMECs at different infection times. The PCA score plots (two principal 
components (2 PCs); R2X = 0.422, 0.458, and 0.413 for 6, 24, and 48 hpi, respectively) showed that 
spectra of infected cells were separated from those of uninfected cells along PC1 (Figure 7A). To 
obtain a better discrimination between the spectra of infected and uninfected cells, PLS-DA was 
applied. The PCA score plots showed minor separations between the indicated groups at 6 and 24 h, 
but separation became more evident at 48 hpi. As shown in Figure 7B, spectra of infected and 
uninfected cells were unambiguously divided into two distinctive groups based on their metabolite 
profile (2PCs; R2X = 0.352, 0.244, and 0.385 for 6, 24, and 48 hpi, respectively). The cross-validation 
plots of the PLS-DA model had R2 Y = 1.662 and Q2 = −0.0536 at 6 hpi and R2Y = 1.782, Q2 = −0.31 at 24 
hpi. However, cross-validation analysis at 48 hpi showed that R2Y and Q2 intercepts were 1.768 and 
0.928, respectively, suggesting goodness of fit and robust predictive power of the model. To identify 
the main metabolites responsible for discriminating infected from uninfected cells, the OPLS-DA 
model was applied. As shown in Figure 7C, the OPLS-DA score plots (2 PCs; R2X = 0.264 for 48 hpi) 
indicated a separation of the spectra of infected cells from those of uninfected cells along PC1. The 
color map of the coefficient loading plots revealed significant variations in the abundance of some 
metabolites between infected and uninfected cells. Lactate, alanine, acetate, glutamine, and creatine 
were more abundant at 48 hpi in infected compared to uninfected cells. In contrast, a reduction in the 
level of glutamate, aspartate, choline and myo-inositol, and glycerol was noted in infected compared 
to uninfected cells. Interestingly, 1H NMR profiling of the purified parasites identified, based on the 
chemical shifts and signal multiplicity, lactate, acetate, glutamate, glycerophosphocholine, scyllo-
inositol, taurine, myo-inositol, and glycerol (Figure S2). 
3.5. Verapamil Inhibits T. gondii Growth and Reduces Barrier Permeability in Infected Cells 
The antiparasitic activity of three concentrations of verapamil (1 µM, 10 µM and 100 µM) was 
assessed at three different time points during the parasite infection cycle: (i) Pre-infection treatment 
(3 h of drug exposure prior to infection), (ii) early treatment (3 hpi), and (iii) late treatment (24 hpi). 
The number of parasites egressing from cells was counted with a hemocytometer at 72 hpi. The 
analysis revealed significant main effects of group (F (3, 7) = 314.6, p < 0.0001) and time (F (2, 14) = 
794.8, p < 0.0001), as well as a significant group x time interaction (F (6, 14) = 11.36, p = 0.0001). Post-
hoc testing revealed that pre-infection treatment with 10 and 100 µM of verapamil significantly 
decreased tachyzoite numbers, compared to vehicle (p < 0.0001). Early treatment with all three 
concentrations of verapamil also resulted in a significant decrease in the number of tachyzoites, 
compared to vehicle (p < 0.0001). Late treatment with 10 and 100 µM of verapamil also significantly 
decreased tachyzoite numbers, compared to vehicle and to 1 µM of verapamil (p < 0.0001). 
Interestingly, early treatment with 1 µM of verapamil significantly decreased tachyzoite numbers, 
compared to vehicle (p < 0.05), suggesting the importance of early treatment in controlling the 
proliferation of the parasite. Overall, verapamil had a significant inhibitory effect on parasite growth 
at each treatment time point examined (Figure 8A). We also examined the effect of verapamil (1 µM, 
10 µM and 100 µM) on the resistance of T. gondii-infected compared to control cells up to 120 hpi 
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using the TEER assay (Figure 8B). The analysis revealed significant main effects of group (F (4, 7) = 
59.47, p < 0.0001) and time (F (6, 42) = 86.66, p < 0.0001), as well as a significant group x time interaction 
(F (24, 42) = 11.93, p < 0.0001). Post-hoc testing revealed no differences in resistance between control 
cells and the infected cells treated with any concentration of verapamil from 0–6 hpi (p > 0.05). From 
24–120 hpi, resistance was significantly reduced in the infected, compared to the control, cells 
regardless of the verapamil concentration (p < 0.0001). However, from 48–120 hpi, verapamil resulted 
in a significant concentration-related increase in resistance in infected cells, compared to untreated 
infected cells (48–96 hpi: p < 0.01; 120 hpi: p < 0.05). This indicates that verapamil partially mitigated 
the increase in cell monolayer permeability caused by T. gondii infection. 
 
Figure 7. Metabolomic profiling revealed distinct changes in metabolites between T. gondii-infected 
and control cells. (A) PCA score plots of metabolites of infected and uninfected BMECs at 6, 24, and 
48 hpi. Infected cells were slightly separated from uninfected cells along PC1 (R2X = 0.262, 0.309, and 
0.272 for 6, 24, and 48 hpi, respectively). Each point in the plot represents one replicate 1H NMR 
spectra. Gray and red circles denote control and infected samples, respectively. (B) PLS-DA score 
plots (top row) and cross-validation plots (bottom row) of the metabolites. Infected BMECs were 
separated from uninfected cells along PLS-DA (R2X = 0.163, 0.11, and 0.182 at 6, 24, and 48 hpi, 
respectively). (C) OPLS-DA score plots (left) and corresponding coefficient loading plots (right) 
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derived from 1H NMR spectra of infected and uninfected cells at 48 hpi. Infected cells were separated 
from uninfected cells along OPLS-DA 1 (R2X = 0.0872). The color scaling map on the right-hand side 
of the coefficient loading plot shows the significance of metabolite variations between infected and 
uninfected cells. Peaks oriented upward (positive direction) and downward (negative direction) 
indicate metabolites that are more or less abundant, respectively, in infected cells compared to control 
cells. The red and blue colors denote increased and decreased levels of metabolites, respectively. The 
peak height is expressed in arbitrary units (a.u.) relative to the total peak contribution. UN indicates 
unknown metabolite. 
 
Figure 8. Verapamil inhibited parasite growth and improved barrier function. (A) Early treatment 
with all three concentrations and pre-infection treatment with two concentrations (10 and 100 µM) of 
verapamil significantly decreased tachyzoite numbers, compared to vehicle control. Late treatment 
with 10 and 100 µM of verapamil also significantly decreased tachyzoite numbers, compared to 
vehicle and to 1 µM of verapamil. (B) No differences were detected in resistance between control and 
infected cells treated with any concentration of verapamil from 0–6 hpi (p > 0.05). From 24–120 hpi, 
resistance was significantly reduced in the infected, compared to the control, cells regardless of the 
verapamil concentration. However, from 48–120 hpi, verapamil resulted in a significant 
concentration-related increase in resistance in infected cells, compared to untreated infected cells. * p 
<0.05; ** p < 0.01; **** p < 0.0001. 
4. Discussion 
Using BMECs as a simple in vitro BBB model, we showed that T. gondii can infect these cells, 
compromise the intercellular barrier structure and permeability, disrupt cell monolayer resistance, 
and alter the lipid and metabolomic profiles of infected cells. 
4.1. Reduced Viability and Altered Structure of Infected Cells 
The metabolic activity of BMECs was decreased in T. gondii-infected cells 48 hpi. This was 
probably due to the high energy demand of parasite replication. T. gondii alters the metabolism of the 
host cells or tissues because the parasite exploits host-derived nutrients for its own metabolic 
processes [22–26]. AO staining enabled the visualization of the progressive development of 
tachyzoites over 48 hpi. A discernible increase is noted in the surface area corresponding to 
tachyzoites at 48 hpi. The parasite growth pattern was similar to that observed in human retinal cells 
[23], macrophages [27], and astrocytoma-derived cells [28] infected by T. gondii. Tachyzoites invaded 
and replicated within cells and, by 48 hpi, several replications had occurred, suggesting that T. gondii 
may enter the human brain by directly interacting with, replicating within, lysing, and breaching the 
local vascular cells. Previous studies have reported a similar mechanism in polarized epithelial and 
trophoblastic monolayers [29], in human retinal endothelial cells [30], and in vascular endothelial 
cells in mice [11]. Ultrastructural analysis revealed damage to cells and diminished integrity of tight 
junctions. Tachyzoites were observed closely engaged with the cells, and other tachyzoites were 
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exiting from cells after they completed their development. This finding concurs with results observed 
in Vero cells infected by T. gondii tachyzoites [31]. 
4.2. Perturbed Lipid Homeostasis in Infected Cells 
T. gondii can both synthesize fatty acids (FAs) de novo, via the fatty acid synthase (FAS) I and 
FAS II systems, and scavenge FAs from its host cells [32]. Intracellular T. gondii can acquire selected 
exogenous fatty acids [33], which are rapidly converted into triacylglycerols and cholesteryl esters 
[34]. We investigated whether cells modulate their lipid repertoire upon infection. Staining with the 
fluorescent dye LipidTox™ revealed an increase in the formation of LDs in T. gondii-infected cells. 
More LDs were detected adjacent to the parasite and around the PV. The recruitment of lipids by T. 
gondii may be part of a survival strategy by the parasite to surmount a deficiency of cholesterol and 
other lipids [22,35]. An increase in the content of LDs was also reported in human foreskin fibroblasts 
[36] and skeletal muscle cells [37], where T. gondii infection increased the biogenesis and recruitment 
of LDs in a time course-dependent manner to the PVM. 
4.3. Compromised Barrier Integrity and Increased Parasite Crossing 
We found that invasion of cells by T. gondii adversely affects the integrity of the BMEC 
monolayer, confirming results reported in GFP+ tachyzoites infecting rat endothelial cells [9]. This 
was supported by disruption in the intercellular barrier formation observed at 24 and 48 hpi using 
SEM and TEM. Wider intercellular gaps were also observed in retinal pigment epithelium (ARPE-19) 
cells infected by T. gondii [38]. In further support of our findings, T. gondii was found to decrease 
resistance of colorectal adenocarcinoma-derived Caco-2 cells and impair the integrity of the intestinal 
mucosa via disruption of TJ proteins, including a decrease in occludin and ZO-1 expression, and 
redistribution of claudin-1, occludin, and ZO-1 in the cytoplasm of intestinal epithelial cells [39]. 
We also examined the migration of T. gondii across the cell monolayer and found that a small 
number of tachyzoites crossed the monolayer between 6–24 hpi, which may imply a paracellular 
crossing method because by 24 h the tachyzoites have not exited the host cells yet. The dramatic 
increase in the number of tachyzoites crossing the cell monolayer after 48 h correlates with the 
increased FITC-dextran leakage. Thus, it can be assumed that ~48 h is the time at which tachyzoites 
start to exit and damage the cells, resulting in increased permeability, number of tachyzoites crossing, 
and FITC-dextran leakage. The increased cell monolayer permeability observed in the present study 
may be a direct effect of tachyzoite invasion or induced indirectly via immune and inflammatory 
responses elicited against T. gondii infection. Disruption of TJs can be induced by inflammatory 
mediators and free radicals in response to infection [40–42]. Cell rupture that accompanies T. gondii 
egress has been suggested as an explanation for cell damage, causing an overwhelming increase in 
the number of tachyzoites and increased permeability [43]. Therefore, the decrease in the number of 
tachyzoites crossing the insert membrane after 96 h could be due to the cells being completely 
destroyed by that time, resulting in few parasites actually left in the inserts to cross over. Indeed, 
significant damage and loss of integrity of the infected cell monolayer was observed on the insert 
membrane stained with AO and CFSE. 
4.4. Infection-Induced Metabolic Alterations 
1H NMR analysis was used to study the metabolic profiles of BMECs infected by T. gondii. 
Lactate, alanine, acetate, glutamine, and creatine were elevated at 48 hpi in infected cells. In contrast, 
a reduction of glutamate, aspartate, choline, myo-inositol, and glycerol was noted in infected cells. 
Alterations of these metabolites are expected because survival and replication of T. gondii depends 
on the ability of the parasite to acquire most of its needed macromolecules from the host cell [24–26]. 
This highly exploitative relationship induces metabolic pressure on host cells in order to cope with 
the nutritional needs of the growing parasites [23,24]. T. gondii tachyzoites rely on glucose as a carbon 
source to meet their bioenergy demands for growth [44,45]. Glucose is converted to lactate, alanine, 
and acetate via glycolysis [46]. An enhanced rate of glycolysis caused an increase in the production 
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of pyruvate, which can be transaminated to lactate via anaerobic glycolysis and to alanine via aerobic 
glycolysis. The increased glycolytic activity may provide an alternative source of energy when 
oxidative phosphorylation is compromised by the impaired mitochondrial function that occurs 
during T. gondii infection [47]. Similar results were observed in erythrocytes infected by Plasmodium 
berghei [48,49]. Alanine can also be synthesized from branched chain amino acids, such as valine, 
leucine, and isoleucine. The acetate level was also increased in infected cells, which has also been 
observed in erythrocytes infected by P. berghei [50]. The increase of acetate in infected cells may be 
attributed to the biosynthesis activity of T. gondii tachyzoites. A previous study using 1H-NMR 
showed that lactic acid and acetic acid are the major end-products of glucose metabolism in T. gondii 
tachyzoites isolated from peritoneal exudate of experimentally infected mice [51]. Our 1H-NMR 
spectroscopic profiling of in vitro-grown tachyzoites showed a similar result, providing evidence for 
the crucial role of lactic acid and acetic acid in the metabolism of T. gondii. 
T. gondii-infected cells also exhibited an elevated level of glutamine and a reduction of glutamate 
at 48 hpi. T. gondii relies on glutamine as a carbon source to meet its energy demands during the 
scarcity of glucose [52–54]. Glutamine is converted to glutamate and utilized by the mitochondria 
cellular respiration cycle as either α-ketoglutarate or to succinate via the γ-aminobutyric acid (GABA) 
shunt. Alteration in the level of glutamine was also detected in mice infected by T. gondii [44], in mice 
infected with Schistosoma mansoni [55], and in primary human foreskin fibroblasts infected by 
Vaccinia virus [56]. The level of aspartate was also decreased in BMECs. The enzyme aspartate 
transaminase can convert glutamate and oxaloacetate to aspartate and 2-oxoglutarate, depending on 
the availability of amino acids and cellular respiration cycle intermediates. The level of choline was 
decreased in infected BMECs, probably caused via uptake by T. gondii from the host [57]. Although 
T. gondii can synthesize certain phospholipids, it acquires choline from host cells to ensure enough 
synthesis of phosphatidylcholine, which is necessary for its replication. Phosphatidylcholine is the 
most abundant phospholipid in T. gondii, accounting for ~75% of the total phospholipids [57]. Altered 
choline was also observed in human foreskin fibroblasts infected by T. gondii [22,57] and in mice 
infected by Schistosoma mansoni [55]. The level of myo-inositol was decreased in infected BMECs. 
Myo-inositol is a building block for all inositol-containing phospholipids in pathogens. Inositol is 
converted to phosphatidylinositol in the Golgi apparatus by phosphatidyl-inositol synthase [58]. 
Reduced inositol was also detected in mice infected by Schistosoma japonicum [59]. In our study, an 
elevated creatine level at 48 hpi may indicate a process of the host response to the infection. Creatine 
is converted to phosphocreatine by mitochondrial creatine phosphokinase (CPK) [60,61]. Increased 
CPK in the serum has been previously associated with toxoplasmosis [62] and malaria [63]. 
4.5. Verapamil Ameliorated the Impact of T. gondii on Barrier Integrity 
Verapamil treatment seemed to significantly offset the adverse effect of infection on the cell 
monolayer permeability from 48 h after treatment onwards in a dose-dependent manner. In a recent 
study, verapamil was shown to inhibit T. gondii crossing of BMECs from 1 µM concentration [64]. 
Similarly, verapamil caused a significant inhibition of the proliferation of T. gondii tachyzoites in a 
dose-dependent way. The antiparasitic effect was more prominent when the drug was applied 24 hpi 
compared to treatment at 3 hpi or prior to infection. These results confirmed our hypothesis that 
verapamil, by limiting parasite growth, could enhance cell monolayer integrity and showed that 
BMECs can be a potential target of this calcium channel-blocking compound, providing a simple BBB 
model for future testing to modulate endothelial barrier permeability and/or limit brain infection. 
Whether the enhancement in cell monolayer integrity associated with verapamil treatment is 
attributed to its direct antiparasitic effect or to a modulatory effect on the P-gp transporter or other 
biological functions in the BMECs remains to be investigated. Also, it remains to be confirmed 
whether the ameliorative effect of verapamil observed in vitro is reflective of the in vivo setting. 
5. Conclusions 
This study showed the ability of T. gondii to invade, grow, and replicate within BMECs, and to 
disrupt their viability, lipid synthesis, and structural integrity, as well as induce BMEC barrier 
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dysfunction. This involved reorganization of the host cell organelles around the PV to support 
parasite growth and replication. In addition, T. gondii induced changes in lipid homeostasis in 
infected cells, presumably to facilitate its multiplication. T. gondii also increased BMEC permeability 
and disrupted the cell monolayer integrity. Differences were detected in the metabolic profile of 
infected cells. T. gondii affected mainly amino acid and fatty acid metabolism of the host cells. Our 
data also showed the potential of 1H NMR coupled with multivariate statistical analysis to identify 
infection-related metabolomic signatures that can be used in future studies to predict the progression 
of the toxoplasmosis disease process. Our results also showed that verapamil inhibited T. gondii 
proliferation and countered the disrupting effect of infection on cell integrity and permeability, 
limiting transmigration of tachyzoites through the cell monolayers. Understanding the mechanisms 
that regulate these processes, whether mediated by host-derived factors secreted in response to 
infection or attributed to effector molecules secreted by T. gondii, remains to be fully elucidated. 
Supplementary Materials: The following are available online at www.mdpi.com/2076-2607/8/9/1386/s1, Figure 
S1: AO staining of infected BMECs over 48 hpi. A significant increase was observed in the AO-stained surface 
area over time (6 vs 48 hpi [**** p < 0.0001]; 24 vs 48 hpi [*** p < 0.001]), Figure S2: Representative 1H NMR spectra 
of purified Toxoplasma gondii tachyzoites, Table S1: Metabolites and their 1H chemical shifts identified in the 
extracts of T. gondii-infected compared to uninfected control BMECs. 
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